Global Transcriptomics Technologies Market Insights, Forecast to 2029

Publication ID:

PB504230965

Publication Date:

May 29, 2023

Pages:

112

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Market Analysis and Insights: Global Transcriptomics Technologies Market
The global Transcriptomics Technologies market is projected to grow from US$ 3883.7 million in 2023 to US$ 4503.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 27% .The key manufacturers are Thermo Fisher Scientif
Report Includes
This report presents an overview of global market for Transcriptomics Technologies market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Transcriptomics Technologies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Transcriptomics Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transcriptomics Technologies revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Transcriptomics Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Transcriptomics Technologies revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., Life Technologies Corporation, Qiangen N.V., LC Sciences and Sigma-Aldrich Corp, etc.
By Company
Affymetrix, Inc.
Thermo Fisher Scientific
Agilent Technologies
F-Hoffmann La Roche Ltd.
Illumina, Inc.
Life Technologies Corporation
Qiangen N.V.
LC Sciences
Sigma-Aldrich Corp
Danaher Corp
Segment by Type
Microarrays
Polymerase Chain Reaction (PCR)
Gene Regulation Technologies
Next Generation Sequencing (NGS)
Segment by Application
Clinical Diagnostics
Drug Discovery and Research
Bioinformatics
Comparative Transcriptomics Studies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Transcriptomics Technologies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptomics Technologies companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptomics Technologies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptomics Technologies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Microarrays
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Gene Regulation Technologies
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Transcriptomics Technologies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery and Research
1.3.4 Bioinformatics
1.3.5 Comparative Transcriptomics Studies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptomics Technologies Market Perspective (2018-2029)
2.2 Global Transcriptomics Technologies Growth Trends by Region
2.2.1 Transcriptomics Technologies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transcriptomics Technologies Historic Market Size by Region (2018-2023)
2.2.3 Transcriptomics Technologies Forecasted Market Size by Region (2024-2029)
2.3 Transcriptomics Technologies Market Dynamics
2.3.1 Transcriptomics Technologies Industry Trends
2.3.2 Transcriptomics Technologies Market Drivers
2.3.3 Transcriptomics Technologies Market Challenges
2.3.4 Transcriptomics Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Transcriptomics Technologies by Players
3.1.1 Global Transcriptomics Technologies Revenue by Players (2018-2023)
3.1.2 Global Transcriptomics Technologies Revenue Market Share by Players (2018-2023)
3.2 Global Transcriptomics Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transcriptomics Technologies, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Transcriptomics Technologies Market Concentration Ratio
3.4.1 Global Transcriptomics Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptomics Technologies Revenue in 2022
3.5 Global Key Players of Transcriptomics Technologies Head office and Area Served
3.6 Global Key Players of Transcriptomics Technologies, Product and Application
3.7 Global Key Players of Transcriptomics Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptomics Technologies Breakdown Data by Type
4.1 Global Transcriptomics Technologies Historic Market Size by Type (2018-2023)
4.2 Global Transcriptomics Technologies Forecasted Market Size by Type (2024-2029)
5 Transcriptomics Technologies Breakdown Data by Application
5.1 Global Transcriptomics Technologies Historic Market Size by Application (2018-2023)
5.2 Global Transcriptomics Technologies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transcriptomics Technologies Market Size (2018-2029)
6.2 North America Transcriptomics Technologies Market Size by Type
6.2.1 North America Transcriptomics Technologies Market Size by Type (2018-2023)
6.2.2 North America Transcriptomics Technologies Market Size by Type (2024-2029)
6.2.3 North America Transcriptomics Technologies Market Share by Type (2018-2029)
6.3 North America Transcriptomics Technologies Market Size by Application
6.3.1 North America Transcriptomics Technologies Market Size by Application (2018-2023)
6.3.2 North America Transcriptomics Technologies Market Size by Application (2024-2029)
6.3.3 North America Transcriptomics Technologies Market Share by Application (2018-2029)
6.4 North America Transcriptomics Technologies Market Size by Country
6.4.1 North America Transcriptomics Technologies Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Transcriptomics Technologies Market Size by Country (2018-2023)
6.4.3 North America Transcriptomics Technologies Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Transcriptomics Technologies Market Size (2018-2029)
7.2 Europe Transcriptomics Technologies Market Size by Type
7.2.1 Europe Transcriptomics Technologies Market Size by Type (2018-2023)
7.2.2 Europe Transcriptomics Technologies Market Size by Type (2024-2029)
7.2.3 Europe Transcriptomics Technologies Market Share by Type (2018-2029)
7.3 Europe Transcriptomics Technologies Market Size by Application
7.3.1 Europe Transcriptomics Technologies Market Size by Application (2018-2023)
7.3.2 Europe Transcriptomics Technologies Market Size by Application (2024-2029)
7.3.3 Europe Transcriptomics Technologies Market Share by Application (2018-2029)
7.4 Europe Transcriptomics Technologies Market Size by Country
7.4.1 Europe Transcriptomics Technologies Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Transcriptomics Technologies Market Size by Country (2018-2023)
7.4.3 Europe Transcriptomics Technologies Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Transcriptomics Technologies Market Size (2018-2029)
8.2 China Transcriptomics Technologies Market Size by Type
8.2.1 China Transcriptomics Technologies Market Size by Type (2018-2023)
8.2.2 China Transcriptomics Technologies Market Size by Type (2024-2029)
8.2.3 China Transcriptomics Technologies Market Share by Type (2018-2029)
8.3 China Transcriptomics Technologies Market Size by Application
8.3.1 China Transcriptomics Technologies Market Size by Application (2018-2023)
8.3.2 China Transcriptomics Technologies Market Size by Application (2024-2029)
8.3.3 China Transcriptomics Technologies Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Transcriptomics Technologies Market Size (2018-2029)
9.2 Asia Transcriptomics Technologies Market Size by Type
9.2.1 Asia Transcriptomics Technologies Market Size by Type (2018-2023)
9.2.2 Asia Transcriptomics Technologies Market Size by Type (2024-2029)
9.2.3 Asia Transcriptomics Technologies Market Share by Type (2018-2029)
9.3 Asia Transcriptomics Technologies Market Size by Application
9.3.1 Asia Transcriptomics Technologies Market Size by Application (2018-2023)
9.3.2 Asia Transcriptomics Technologies Market Size by Application (2024-2029)
9.3.3 Asia Transcriptomics Technologies Market Share by Application (2018-2029)
9.4 Asia Transcriptomics Technologies Market Size by Region
9.4.1 Asia Transcriptomics Technologies Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Transcriptomics Technologies Market Size by Region (2018-2023)
9.4.3 Asia Transcriptomics Technologies Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Transcriptomics Technologies Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Transcriptomics Technologies Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Transcriptomics Technologies Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Affymetrix, Inc.
11.1.1 Affymetrix, Inc. Company Details
11.1.2 Affymetrix, Inc. Business Overview
11.1.3 Affymetrix, Inc. Transcriptomics Technologies Introduction
11.1.4 Affymetrix, Inc. Revenue in Transcriptomics Technologies Business (2018-2023)
11.1.5 Affymetrix, Inc. Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Transcriptomics Technologies Introduction
11.2.4 Thermo Fisher Scientific Revenue in Transcriptomics Technologies Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Transcriptomics Technologies Introduction
11.3.4 Agilent Technologies Revenue in Transcriptomics Technologies Business (2018-2023)
11.3.5 Agilent Technologies Recent Developments
11.4 F-Hoffmann La Roche Ltd.
11.4.1 F-Hoffmann La Roche Ltd. Company Details
11.4.2 F-Hoffmann La Roche Ltd. Business Overview
11.4.3 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Introduction
11.4.4 F-Hoffmann La Roche Ltd. Revenue in Transcriptomics Technologies Business (2018-2023)
11.4.5 F-Hoffmann La Roche Ltd. Recent Developments
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Details
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. Transcriptomics Technologies Introduction
11.5.4 Illumina, Inc. Revenue in Transcriptomics Technologies Business (2018-2023)
11.5.5 Illumina, Inc. Recent Developments
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Details
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Transcriptomics Technologies Introduction
11.6.4 Life Technologies Corporation Revenue in Transcriptomics Technologies Business (2018-2023)
11.6.5 Life Technologies Corporation Recent Developments
11.7 Qiangen N.V.
11.7.1 Qiangen N.V. Company Details
11.7.2 Qiangen N.V. Business Overview
11.7.3 Qiangen N.V. Transcriptomics Technologies Introduction
11.7.4 Qiangen N.V. Revenue in Transcriptomics Technologies Business (2018-2023)
11.7.5 Qiangen N.V. Recent Developments
11.8 LC Sciences
11.8.1 LC Sciences Company Details
11.8.2 LC Sciences Business Overview
11.8.3 LC Sciences Transcriptomics Technologies Introduction
11.8.4 LC Sciences Revenue in Transcriptomics Technologies Business (2018-2023)
11.8.5 LC Sciences Recent Developments
11.9 Sigma-Aldrich Corp
11.9.1 Sigma-Aldrich Corp Company Details
11.9.2 Sigma-Aldrich Corp Business Overview
11.9.3 Sigma-Aldrich Corp Transcriptomics Technologies Introduction
11.9.4 Sigma-Aldrich Corp Revenue in Transcriptomics Technologies Business (2018-2023)
11.9.5 Sigma-Aldrich Corp Recent Developments
11.10 Danaher Corp
11.10.1 Danaher Corp Company Details
11.10.2 Danaher Corp Business Overview
11.10.3 Danaher Corp Transcriptomics Technologies Introduction
11.10.4 Danaher Corp Revenue in Transcriptomics Technologies Business (2018-2023)
11.10.5 Danaher Corp Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Affymetrix, Inc.
Thermo Fisher Scientific
Agilent Technologies
F-Hoffmann La Roche Ltd.
Illumina, Inc.
Life Technologies Corporation
Qiangen N.V.
LC Sciences
Sigma-Aldrich Corp
Danaher Corp

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂